Skip to the lineages
Regenerative Medicine

What Clinical Evidence Supports IV Glutathione for Wellness?

Published November 16, 2026

Protocol: 7 steps in this guide
  1. What glutathione is
  2. IV glutathione versus oral supplements
  3. What trials have studied, and the vitamin C problem
  4. Skin and fatigue claims versus outcomes studied
  5. The 2026 FDA warning and CDC investigation
  6. Sterility, ingredient grade and compounding standards
  7. What informed consent should disclose

Very little. A 2026 review of IV glutathione for skin lightening, a cosmetic use it is promoted for, found only “limited evidence of modest, varied skin pigmentation improvements” from small studies and concluded that the evidence “is too limited to justify routine use.” Evidence for broader wellness claims such as detoxification, immunity or energy is no stronger. Meanwhile, in 2026 FDA and CDC reported illnesses linked to injectable glutathione made from a dietary-supplement-grade ingredient. CDC states that there are no FDA-approved glutathione products in the United States.

What glutathione is

CDC describes glutathione, on its page on adverse events linked to injectable glutathione compounded with dietary supplement grade ingredient, as “an antioxidant that occurs naturally in the body.” It notes that in the United States glutathione “is sold as a dietary supplement taken by mouth and promoted for purposes such as skin brightening, immune support, detoxification, and increased energy.” A substance the body makes, and that is sold as a supplement, is not thereby shown to help when injected.

IV glutathione versus oral supplements

Because, as CDC states, “There are no FDA-approved glutathione products in the United States,” IV glutathione given in the U.S. is a compounded preparation, and the products in the 2026 reports were made by compounding pharmacies. The quality of each product depends on the pharmacy and on its ingredients. Dietary supplements are regulated differently from drugs, and an ingredient made for a supplement is not made to be injected. FDA’s compounding communication, FDA reminds compounders not to use dietary supplement grade glutathione for injectables, states that “Ingredients labeled for dietary supplement use may contain impurities and contaminants, including endotoxins, that may be harmful when administered as an injectable drug.”

What trials have studied, and the vitamin C problem

The 2026 narrative review in the Journal of Medicine and Life, Glutathione for skin lightening via intravenous, oral, and topical routes, searched the literature through March 2026. It found studies “generally limited by small sample sizes, methodological differences, the absence of standardized outcomes, and limited follow-up.” It also points to a specific confounder: “the regular co-administration of vitamin C has made it difficult to know the independent effect of IV GSH” (GSH is glutathione). A drip that contains more than one ingredient cannot show which one, if any, did something.

Skin and fatigue claims versus outcomes studied

The outcome the review examined was skin pigmentation, not energy, immunity or detoxification. It describes the biological rationale, effects on the pathway that makes skin pigment, but states that “translating these mechanisms into clinically meaningful outcomes remains uncertain.” Claims that IV glutathione boosts energy or immunity in healthy people are not supported by the evidence this review assessed; broader energy claims for IV drips are covered in whether IV vitamin drips improve energy without a diagnosed deficiency. The review also lists safety concerns, “hepatotoxicity, hypersensitivity reactivity, and potential renal and endocrine effects.”

The 2026 FDA warning and CDC investigation

Two agencies reported on the same problem with different counts at different times. The numbers should not be added together.

Agency Date What it reported
FDA August 27, 2026 Reports of "at least 30 patients" with adverse events after IV glutathione, alone or with other ingredients; glutathione from Medisca Inc. (Lot #229536) labeled dietary supplement grade; two Texas pharmacies recalled products over elevated endotoxin
CDC September 15, 2026 (marked updated September 11, 2026) Reports of "over 25 people becoming sick in at least four states: Texas, Washington, Florida, and New York"; at least three hospitalized, all after IV glutathione; one critically ill; at least three Texas pharmacies had recalled products over high endotoxin levels

FDA listed reported reactions including “fever, chills, pain, dizziness, signs of shock and sepsis-like symptoms, with some resulting in hospitalizations,” and said these are “consistent with exposure to excessive endotoxin levels.” CDC states that the illnesses “are likely linked to elevated levels of endotoxins in the injected products” and that reactions “can be severe and may require emergency medical care.” These reports concern contaminated products. They are not a rate of harm for all IV glutathione, and they are not evidence about whether glutathione works.

Sterility, ingredient grade and compounding standards

FDA states that compounders “are responsible for ensuring all components used in injectable drugs are appropriate for their intended use and should not use dietary supplement grade ingredients when making injectable drugs.” It recommends that health care professionals “check with their compounders regarding the source of the glutathione used to make injectable drugs.” CDC adds that providers should follow recall notices and contact patients who received affected products. Problems can be reported to FDA’s MedWatch program, as explained in how adverse events from unapproved regenerative products are reported.

What informed consent should disclose

A clinic offering IV glutathione should be able to tell you, in writing:

  1. that there is no FDA-approved glutathione product and the injection is compounded;
  2. which pharmacy compounded it, and that the glutathione is a grade intended for injection;
  3. what else is in the drip, such as vitamin C;
  4. what outcome they expect, and what evidence supports it;
  5. the risks, including reactions to contaminants, and what to do if you develop fever, chills or dizziness.

What consent for an experimental product should include is covered in what should be included in informed consent for an experimental biologic injection.

Clinical evidence does not support IV glutathione for wellness, detoxification or energy, and even its studied cosmetic use rests on small, confounded trials, while 2026 FDA and CDC reports linked contaminated compounded glutathione to serious illness, so the risks of an IV drip are better established than its benefits.

Cells linked to this one

This guide leads on to

Lineage G: Intravenous Therapy

What readers added

Add a remark

Your email address will not be published. Required fields are marked *